Alpha-1 Biologics Overview

  • Founded
  • 2011
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • (Cancelled)
  • Latest Deal Amount
  • $200K
Latest Deal Amount
  • Investors
  • 2

Alpha-1 Biologics General Information


Developer of a biotechnology designed to develop drugs and diagnostic tests. The company's biotechnology provide several critical functions including protection of discoveries, translation of discoveries and preparation of statistical analyses and reports to support safety and efficacy, enabling researchers to regulate cholesterol levels transported by immune cells.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Primary Office
  • 25 Health Sciences Drive
  • Suite 110
  • NY 11790
  • United States
+1 (631) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Alpha-1 Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) $200K Cancelled Startup
2. Angel (individual) 00.00 00.00 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Alpha-1 Biologics’s complete valuation and funding history, request access »

Alpha-1 Biologics Executive Team (2)

Name Title Board Seat Contact Info
Cynthia Bristow Ph.D Founder, Chief Executive Officer, Chief Scientific Officer & Board Member
To view Alpha-1 Biologics’s complete executive team members history, request access »

Alpha-1 Biologics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Long Island High Technology Incubator Accelerator/Incubator 000 0000 000000 0
Ronald Winston Angel (individual) Minority 000 0000 000000 0
To view Alpha-1 Biologics’s complete investors history, request access »